Tarsus Pharmaceuticals Inc (TARS) — Capital Reinvestment Ratio
Tarsus Pharmaceuticals Inc (TARS) has a Capital Reinvestment Ratio of 0.06x as of June 2026, meaning it reinvests 0% of its operating cash flow ($66.77 Million) in capital expenditures ($4.07 Million). Check TARS goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Tarsus Pharmaceuticals Inc Capital Reinvestment Ratio (2021–2021)
This chart tracks Tarsus Pharmaceuticals Inc's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see TARS operating cash flow.
Annual Capital Reinvestment Ratio for Tarsus Pharmaceuticals Inc (2021–2021)
Year-by-year Capital Reinvestment Ratio for Tarsus Pharmaceuticals Inc from 2021 to 2021. See free cash flow generation of Tarsus Pharmaceuticals Inc to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 0.16x | $3.75 Million | $586.00K | — |